Next Article in Journal
Chemically Defined, Efficient Megakaryocyte Production from Human Pluripotent Stem Cells
Previous Article in Journal
Knocking Out Rap1a Attenuates Cardiac Remodeling and Fibrosis in a Male Murine Model of Angiotensin II-Induced Hypertension
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
This is an early access version, the complete PDF, HTML, and XML versions will be available soon.
Article

Reduced RhoGDI2 Expression Disrupts Centrosome Functions and Promotes Mitotic Errors

1
Laboratory of Connective Tissues Biology, GIGA-Cancer, University of Liège, 4000 Liège, Belgium
2
Laboratory for the Analysis of Medicines (LAM), Department of Pharmacy, CIRM, University of Liege, 4000 Liège, Belgium
*
Author to whom correspondence should be addressed.
Cells 2025, 14(22), 1833; https://doi.org/10.3390/cells14221833 (registering DOI)
Submission received: 8 October 2025 / Revised: 7 November 2025 / Accepted: 17 November 2025 / Published: 20 November 2025

Abstract

RhoGDI2 is a RhoGTPase regulator that has roles in cytoskeleton organization and cell survival, amongst others. It is differentially expressed in many cell types and tissues, including several human cancers, where its expression has been correlated with either good or bad prognosis. To identify the underlying mechanisms, we knocked down its expression in human cancer cell lines. We observed that repression of RhoGDI2 expression, but not that of the closely related RhoGDI1, significantly reduces their proliferation rate. In parallel, RhoGDI2 suppression induces supernumerary centrosomes and inhibits ciliogenesis. As RhoGDIs are regulators of GTPases, we checked whether key RhoGTPases are involved in these effects. We found that silencing RhoA partially rescued the induction of supernumerary centrosomes and ciliary defects observed upon RhoGDI2 silencing. It was previously shown that RhoGDI2 is strongly expressed in immune cells and that there are striking similarities between primary cilia and immune synapses. Based on this knowledge, we silenced RhoGDI2 in NK cells and could demonstrate that this strongly affects their immune synapse-related cancer cell-killing activity. Altogether, these data suggest novel roles for RhoGDI2 in centrosome functions in human cancer and immune synapses in immune cells, which provides an explanation for its reported dual role in cancer.
Keywords: RhoGTPases; centrosomes; primary cilia; chromosome congression; immune synapse RhoGTPases; centrosomes; primary cilia; chromosome congression; immune synapse

Share and Cite

MDPI and ACS Style

Tripathi, M.; Garbacki, N.; Willems, J.; Cobraiville, G.; Fillet, M.; Colige, A.; Deroanne, C.F. Reduced RhoGDI2 Expression Disrupts Centrosome Functions and Promotes Mitotic Errors. Cells 2025, 14, 1833. https://doi.org/10.3390/cells14221833

AMA Style

Tripathi M, Garbacki N, Willems J, Cobraiville G, Fillet M, Colige A, Deroanne CF. Reduced RhoGDI2 Expression Disrupts Centrosome Functions and Promotes Mitotic Errors. Cells. 2025; 14(22):1833. https://doi.org/10.3390/cells14221833

Chicago/Turabian Style

Tripathi, Mudrika, Nancy Garbacki, Jérôme Willems, Gaël Cobraiville, Marianne Fillet, Alain Colige, and Christophe F. Deroanne. 2025. "Reduced RhoGDI2 Expression Disrupts Centrosome Functions and Promotes Mitotic Errors" Cells 14, no. 22: 1833. https://doi.org/10.3390/cells14221833

APA Style

Tripathi, M., Garbacki, N., Willems, J., Cobraiville, G., Fillet, M., Colige, A., & Deroanne, C. F. (2025). Reduced RhoGDI2 Expression Disrupts Centrosome Functions and Promotes Mitotic Errors. Cells, 14(22), 1833. https://doi.org/10.3390/cells14221833

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop